Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Acta Biochimica et Biophysica Sinica

• Publication date

  2010-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/ABBS/GMP118PMID 20119625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overcoming drug resistance by enhancing apoptosis of tumor cells.

  2009cited by this paper
• Smac mimetics as new cancer therapeutics

  2009cited by this paper
• Ultrasound-mediated gene transfection.

  2009cited by this paper
• IAPS : More than just inhibitors of apoptosis proteins

  2008cited by this paper
• Inhibitor of apoptosis proteins and apoptosis.

  2008cited by this paper
• Protein–protein recognition as a first step towards the inhibition of XIAP and Survivin anti‐apoptotic proteins

  2008cited by this paper
• Targeting survivin in cancer therapy

  2008cited by this paper
• IAP-targeted therapies for cancer

  2008cited by this paper
• IAPs: what's in a name?

  2008cited by this paper
• X-linked inhibitor of apoptosis protein as a therapeutic target

  2007cited by this paper
• Livin/ML-IAP as a new target for cancer treatment.

  2007cited by this paper
• Livin promotes Smac/DIABLO degradation by ubiquitin–proteasome pathway

  2006cited by this paper
• Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

  2006cited by this paper
• Structural, functional and therapeutic biology of survivin.

  2006cited by this paper
• Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis.

  2005cited by this paper
• RNA interference: From gene silencing to gene-specific therapeutics

  2005cited by this paper
• X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO.

  2005cited by this paper
• XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs

  2005cited by this paper
• The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.

  2004cited by this paper
• X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells.

  2004cited by this paper
• Apoptosis pathways in cancer and cancer therapy

  2004cited by this paper
• siRNAs: applications in functional genomics and potential as therapeutics

  2004cited by this paper
• Noise amidst the silence: off-target effects of siRNAs?

  2004cited by this paper
• Mammalian mitochondrial IAP binding proteins.

  2003cited by this paper
• Why target apoptosis in cancer treatment?

  2003cited by this paper
• Livin, a Novel Inhibitor of Apoptosis Protein Family Member*

  2001cited by this paper
• Apoptosis in cancer.

  2000cited by this paper

• Survivin in lung cancer: a potential target for therapy and prevention—a narrative review

  2024cites this paper
• Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

  2024cites this paper
• Livin expression promotes keratinocyte release of inflammatory mediators in psoriasis

  2024cites this paper
• Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy

  2021cites this paper
• Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.

  2020cites this paper
• Multi-Drug/Gene NASH Therapy Delivery and Selective Hyperspectral NIR Imaging Using Chirality-Sorted Single-Walled Carbon Nanotubes

  2019cites this paper
• Delivery of Survivin siRNA Using Cationic Diphenylalanine Vesicles

  2019cites this paper
• The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes.

  2019cites this paper
• Combination of photodynamic therapy and gene silencing achieved through the hierarchical self-assembly of porphyrin-siRNA complexes.

  2019cites this paper
• Dual targeting of survivin and X-linked inhibitor of apoptosis protein suppresses the growth and promotes the apoptosis of gastric cancer HGC-27 cells

  2018cites this paper
• Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.

  2017cites this paper
• Inhibitors of apoptosis: clinical implications in cancer

  2017cites this paper
• Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins

  2017cites this paper
• Combination therapy of macromolecules and small molecules: approaches, advantages, and limitations

  2017cites this paper
• Survivin, a Promising Gene for Targeted Cancer Treatment.

  2016cites this paper
• Glycoproteomic Characterization of Bladder Cancer Chemoresistant Cells

  2015cites this paper
• Birc2-Amplifikationen bei Plattenepithelkarzinomen des Kopf-Hals-Bereiches und deren Einfluss auf den Tumorphänotyp und die Patientenprognose

  2015cites this paper
• Prognostic value of survivin in patients with non-Hodgkin's lymphoma: a meta-analysis.

  2015cites this paper
• Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells.

  2015cites this paper
• Prognostic Significance of Survivin in Breast Cancer: Meta‐analysis

  2014cites this paper
• Large Molecule Therapeutics Surface-Modi fi ed Nanoparticles Enhance Transurothelial Penetration and Delivery of Survivin siRNA in Treating Bladder Cancer

  2014cites this paper
• Programowana śmierć komórki a białka z rodziny inhibitorów apoptozy (iap) i ich rola w nowotworzeniu

  2014cites this paper
• Livin, Survivin and Caspase 3 as early recurrence markers in non-muscle-invasive bladder cancer

  2014cites this paper
• Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells.

  2013cites this paper
• Surface-Modified Nanoparticles Enhance Transurothelial Penetration and Delivery of Survivin siRNA in Treating Bladder Cancer

  2013cites this paper
• Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients

  2013cites this paper
• Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy

  2013cites this paper
• Zinc sensitizes prostate cancer cells to sorafenib and regulates the expression of Livin.

  2013cites this paper
• Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment

  2013cites this paper
• Livin and caspase-3 expression are negatively correlated in cervical squamous cell cancer.

  2013cites this paper
• RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.

  2013cites this paper
• A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma.

  2013cites this paper
• Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.

  2013influential citation
• Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells

  2012cites this paper
• Research progress in potential urinary markers for the early detection, diagnosis and follow-up of human bladder cancer.

  2012cites this paper
• The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells

  2012cites this paper
• MINI-REVIEW Research Progress in Potential Urinary Markers for the Early Detection, Diagnosis and Follow-up of Human Bladder Cancer

  2012cites this paper
• Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.

  2012cites this paper
• siRNA-mediated inhibition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells.

  2012cites this paper
• Potential use of RNA interference as therapeutic strategy in urologic cancer.

  2011cites this paper
• Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist

  2010cites this paper